These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30196250)

  • 1. Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort.
    Ziad A; Olekhnovitch R; Ruiz F; Berr C; Bégaud B; Goldberg M; Zins M; Mura T
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1107-1115. PubMed ID: 30196250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES Study.
    Ziad A; Berr C; Ruiz F; Bégaud B; Lemogne C; Goldberg M; Zins M; Mura T
    Drug Saf; 2021 May; 44(5):565-579. PubMed ID: 33575980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.
    Swami S; Cohen RA; Kairalla JA; Manini TM
    Drugs Aging; 2016 Nov; 33(11):809-818. PubMed ID: 27638818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.
    Dauphinot V; Mouchoux C; Veillard S; Delphin-Combe F; Krolak-Salmon P
    Alzheimers Res Ther; 2017 Aug; 9(1):58. PubMed ID: 28764796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between using medications with anticholinergic properties and short-term cognitive decline among older men: A retrospective cohort study in Taiwan.
    Wu YH; Wang CJ; Hung CH; Chen LY; Lin MH; Wang PN; Chen LK
    Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():57-64. PubMed ID: 28436193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of anticholinergic drugs on verbal episodic memory function in the elderly: a retrospective, cross-sectional study.
    Fortin MP; Rouch I; Dauphinot V; Gédéon C; Genthon S; Bonnefoy M; Krolak-Salmon P
    Drugs Aging; 2011 Mar; 28(3):195-204. PubMed ID: 21329401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
    Risacher SL; McDonald BC; Tallman EF; West JD; Farlow MR; Unverzagt FW; Gao S; Boustani M; Crane PK; Petersen RC; Jack CR; Jagust WJ; Aisen PS; Weiner MW; Saykin AJ;
    JAMA Neurol; 2016 Jun; 73(6):721-32. PubMed ID: 27088965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
    Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
    J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].
    Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M
    Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study.
    Dos Santos ANM; Junior GAAG; Benseñor IM; Goulart AC; Brunoni AR; Viana MC; Lotufo PA; Suemoto CK
    Eur J Clin Pharmacol; 2022 Sep; 78(9):1527-1534. PubMed ID: 35764818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Effects of Anticholinergic Drugs on Cognition and Mobility: Cutoff for Impairment in a Cross-Sectional Study in Young-Old and Old-Old Adults.
    Attoh-Mensah E; Loggia G; Schumann-Bard P; Morello R; Descatoire P; Marcelli C; Chavoix C
    Drugs Aging; 2020 Apr; 37(4):301-310. PubMed ID: 31930459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review.
    Andre L; Gallini A; Montastruc F; Montastruc JL; Piau A; Lapeyre-Mestre M; Gardette V
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1631-1644. PubMed ID: 31468067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atropinic (anticholinergic) burden in antipsychotic-treated patients.
    Montastruc F; Benevent J; Touafchia A; Chebane L; Araujo M; Guitton-Bondon E; Durrieu G; Arbus C; Schmitt L; Begaud B; Montastruc JL
    Fundam Clin Pharmacol; 2018 Feb; 32(1):114-119. PubMed ID: 28887902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study.
    Krüger C; Schäfer I; van den Bussche H; Bickel H; Fuchs A; Gensichen J; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M
    BMJ Open; 2021 Mar; 11(3):e044230. PubMed ID: 33757948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticholinergic burden in adult and elderly people with intellectual disabilities: Results from an Italian multicenter cross-sectional study.
    De Vreese LP; Mantesso U; De Bastiani E; Marangoni A; Weger E; Gomiero T
    PLoS One; 2018; 13(10):e0205897. PubMed ID: 30379948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Wolfe R; Connors MH; Elliott RA
    J Alzheimers Dis; 2017; 60(2):349-358. PubMed ID: 28869467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.
    Cross AJ; George J; Woodward MC; Ames D; Brodaty H; Ilomäki J; Elliott RA
    Drugs Aging; 2016 Jan; 33(1):37-44. PubMed ID: 26645294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
    Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
    Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing cognitive effects of anticholinergic medications in patients with coronary artery disease.
    Lanctôt KL; O'Regan J; Schwartz Y; Swardfager W; Saleem M; Oh PI; Herrmann N
    Psychosomatics; 2014; 55(1):61-8. PubMed ID: 23993643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.